Zydus Pharmaceuticals (USA) Inc. is recalling 14,748 units of Lansoprazole Delayed-Release Orally Disintegrating Tablets, a medication used to treat stomach acid-related conditions. The recall was initiated because the tablets failed dissolution specifications, meaning the medication may not dissolve at the correct rate in the body. This defect could potentially reduce the effectiveness of the drug or cause it to be released into the system improperly.
The failure to meet dissolution specifications means the tablets may not release the active ingredient properly, which can prevent the patient from receiving the intended therapeutic dose and potentially lead to inadequate treatment of their condition.
Pharmacy refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.